Last updated on April 2018

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Brief description of study

The primary objective of this study is to determine whether the use of PDE5 inhibitors (vardenafil, sildenafil, or tadalafil) increases the risk for the development of NAION.

Detailed Study Description

Collected data will be compared to historic data of the same participant in case-crossover design.

Clinical Study Identifier: NCT00867815

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Advanced Research Institute, Inc.
Trinity, FL United States